Skip to main content
Log in

Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools

  • Investigative Report
  • Published:
European Journal of Dermatology Aims and scope

Abstract

Aim

The aim of this study was to evaluate macrovascular endothelial dysfunction and microvascular damage as clinical markers of peripheral microangiopathy in patients with Raynaud’s phenomenon (RP).

Patients and methods

Seventy-seven secondary RP with systemic sclerosis, 32 primary RP and 34 healthy controls were included in our study. Secondary RP patients were divided into two subgroups: 39 with digital ulcers (DU) and 38 without digital ulcers (non-DU).

Results

Patients with DU had significantly lower flow-mediated dilatation values (5.34 ± 7.49%) compared to non-DU patients (16.21 ± 11.31%), primary RP (17.96 ± 12.78%) and controls (20.17 ± 8.86%), p<0.001, favouring macrovascular endothelium dysfunction. Regarding microvascular damage, the DU group had a predominately capillaroscopic late pattern (71.1%) whereas non-DU patients had an active pattern (56.4%). The microangiopathy evolution score was significantly higher in the DU group compared to the non-DU group (4.79 ± 1.82 vs. 1.79 ± 1.56, p<0.001). Flow-mediated dilation was significantly lower in late pattern (6.13 ± 7.09%) compared to active (12.58 ± 10.66%) and early patterns (17.72 ± 14.90%), p = 0.016 and p = 0.044 respectively.

Conclusions

Low flow-mediated dilatation and microvascular damage in capillaroscopy are early clinical markers of DU risk in RP patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ho M, Veale D, Eastmond C, et al. Macrovascular disease and systemic sclerosis. Ann Rheum Dis 2000; 59: 39–43.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Kasprzak JD, Klosinska M, Drozdz J. Clinical aspects of assessment of endothelial function. Pharmacol Rep 2006; 58(Suppl): 33–40.

    PubMed  Google Scholar 

  3. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension 2007; 49: 748–60.

    Article  PubMed  CAS  Google Scholar 

  4. Harris RA, Nishiyama SK, Wray DW, et al. Ultrasound assessment of flow-mediated dilation. Hypertension 2010; 55: 1075–85.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 2005; 568(Pt 2): 357–69.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158: 595–600.

    Article  PubMed  CAS  Google Scholar 

  7. Cutolo M, Smith V. State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology? Rheumatology (Oxford) 2013; 52: 1933–40.

    Article  Google Scholar 

  8. Cutolo M, Sulli A, Pizzorni C, et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155–60.

    PubMed  CAS  Google Scholar 

  9. Hudson M, Fritzler MJ. Diagnostic criteria of systemic sclerosis. J Autoimmun 2014; 48-49: 38–41.

    Google Scholar 

  10. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5.

    PubMed  CAS  Google Scholar 

  11. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257–65.

    Article  PubMed  Google Scholar 

  12. Cutolo M, Pizzorni C, Secchi ME, et al. Capillaroscopy. Best Pract Res Clin Rheumatol 2008; 22: 1093–108.

    Article  PubMed  Google Scholar 

  13. Sulli A, Secchi ME, Pizzorni C, et al. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 885–7.

    Article  PubMed  CAS  Google Scholar 

  14. Rollando D, Bezante GP, Sulli A, et al. Brachial artery endothelialdependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J Rheumatol 2010; 37: 1168–73.

    Article  PubMed  Google Scholar 

  15. Takahashi T, Asano Y, Amiya E, et al. Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis. Mod Rheumatol 2014; 24: 106–11.

    Article  PubMed  Google Scholar 

  16. Rosato E, Gigante A, Barbano B, et al. In systemic sclerosis macrovascular damage of hands digital arteries correlates with microvascular damage. Microvasc Res 2011; 82: 410–5.

    Article  PubMed  Google Scholar 

  17. Hasegawa M, Nagai Y, Tamura A, et al. Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis. Br J Dermatol 2006; 155: 1159–64.

    Article  PubMed  CAS  Google Scholar 

  18. Schmidt WA, Wernicke D, Kiefer E, et al. Colour duplex sonography of finger arteries in vasculitis and in systemic sclerosis. Ann Rheum Dis 2006; 65: 265–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Bots ML, Westerink J, Rabelink TJ, et al. Assessment of flowmediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005; 26: 363–8.

    Article  PubMed  Google Scholar 

  20. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–5.

    Article  PubMed  CAS  Google Scholar 

  21. Thijssen DH, Black MA, Pyke KE, et al. Assessment of flowmediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011; 300: H2–12.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Lekakis JPC, Mavrikakis M, Stamatelopoulos S. Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud’s phenomenon secondary to systemic sclerosis. Am J Cardiol 1998; 82: 1555–7.

    Article  PubMed  CAS  Google Scholar 

  23. Cypiene A, Laucevicius A, Venalis A, et al. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 2008; 27: 1517–22.

    Article  PubMed  Google Scholar 

  24. Rossi P, Granel B, Marziale D, et al. Endothelial function and hemodynamics in systemic sclerosis. Clin Physiol Funct Imaging 2010; 30: 453–9.

    Article  PubMed  Google Scholar 

  25. Szucs G, Timar O, Szekanecz Z, et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis–relevance for prevention of vascular complications. Rheumatology (Oxford) 2007; 46: 759–62.

    Article  CAS  Google Scholar 

  26. Andersen GN, Mincheva-Nilsson L, Kazzam E, et al. Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 2002; 46: 1324–32.

    Article  PubMed  CAS  Google Scholar 

  27. Roustit M, Simmons GH, Baguet JP, et al. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 2008; 35: 1576–83.

    PubMed  PubMed Central  Google Scholar 

  28. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005; 112: 3337–47.

    Article  PubMed  Google Scholar 

  29. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006; 2: 99–106.

    Article  PubMed  CAS  Google Scholar 

  30. Veale DJ, Collidge TA, Belch JJ. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 1995; 54: 853–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  31. Piccione MC, Bagnato G, Zito C, et al. Early identification of vascular damage in patients with systemic sclerosis. Angiology 2011; 62: 338–43.

    Article  PubMed  Google Scholar 

  32. Le JH, Cho KI. Association between endothelial function and microvascular changes in patients with secondary Raynaud’s phenomenon. Clin Rheumatol 2014; 33: 1627–33.

    Article  PubMed  Google Scholar 

  33. Pistorius MA, de Faucal P, Planchon B, et al. [Importance of the Allen test in the diagnosis of distal arteriopathy in Raynaud’s phenomenon. Prospective study on a continuous series of 576 patients]. J Mal Vasc 1994; 19: 17–21.

    PubMed  CAS  Google Scholar 

  34. Frerix M, Stegbauer J, Dragun D, et al. Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study. Rheumatology (Oxford) 2012; 51: 735–42.

    Article  Google Scholar 

  35. Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 2009; 8: 632–7.

    Article  PubMed  CAS  Google Scholar 

  36. Hervier B, Rimbert M, Colonna F, et al. Clinical significance of anti-Ro/SSA-52 kDa antibodies: a retrospective monocentric study. Rheumatology (Oxford) 2009; 48: 964–7.

    Article  CAS  Google Scholar 

  37. Hudson M, Pope J, Mahler M, et al. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis. Arthritis Res Ther 2012; 14: R50.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivone Silva.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, I., Loureiro, T., Teixeira, A. et al. Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools. Eur J Dermatol 25, 444–451 (2015). https://doi.org/10.1684/ejd.2015.2605

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2015.2605

Key words

Navigation